Pediatrix Medical Group, Inc. — Earnings Quality Grade C
MD · Healthcare
Some red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 44 days, change -3 days YoY
AR growth -11.7% vs revenue growth -4.9%
Revenue -4.9%, CFFO 31.2%. Cash follows revenue
Expense Quality
No material inventory
CapEx growth -16.2% vs revenue -4.9%. Normal
SG&A/Gross Profit = 48.8%. Normal
Gross margin 25.8%, change +3.2pp. Stable
Cash Flow Quality
CFFO/NI = 1.64. Profits backed by cash
FCF $0.3B, FCF/NI = 1.53
Accruals ratio = -4.7%. Low accruals
Cash $0.5B covers 79% of debt $0.6B
Balance Sheet Health
Goodwill+Intangibles $1.3B = 148% of equity. Over 50%
Debt/EBITDA = 2.3x. Healthy
Other assets -24.1% vs revenue -4.9%. Normal
Write-offs normal
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change 2% YoY. Normal
Manipulation Score
M-Score = -2.86 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor MD continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25